The information highlighted (if any) are the most recent updates for this brand.
ABILIFY MAINTENA is contraindicated in patients with a known hypersensitivity to aripiprazole. Hypersensitivity reactions ranging from pruritus/urticaria to anaphylaxis have been reported in patients receiving aripiprazole (see Clinical Trials Experience and Post-marketing Experience under Adverse Reactions).